Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis

Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis

Jan Sperl,1 Sona Frankova,1 Miluse Kreidlova,2 Dusan Merta,3 Monika Tothova,4 Julius Spicak1 1Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 2Institute of Medical Biochemistry and Laboratory Medicine, General University Hospital, Charles University, 3Departm...

Full description

Bibliographic Details
Main Authors: Sperl J, Frankova S, Kreidlova M, Merta D, Tothova M, Spicak J
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Therapeutics and Clinical Risk Management
Subjects:
HCV infection
genotype 3
sofosbuvir
daclatasvir
end-stage renal disease
maintenance hemodialysis
Online Access:https://www.dovepress.com/combination-of-sofosbuvir-and-daclatasvir-in-the-treatment-of-genotype-peer-reviewed-article-TCRM

Internet

https://www.dovepress.com/combination-of-sofosbuvir-and-daclatasvir-in-the-treatment-of-genotype-peer-reviewed-article-TCRM

Similar Items